The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials

Therapeutic Innovation and Regulatory Science

Volumn 52, Issue 2, 2018, Pages 206-213

  Bloom, Diane ^a   Beetsch, Joel ^b   Harker, Matthew ^c   Hesterlee, Sharon ^d   Moreira, Paulo ^e   Patrick Lake, Bray ^f   Selig, Wendy ^g   Sherman, Jeffrey ^h   Smith, Sophia K ⁱ   Valentine, James E ^j   Roberts, Jamie N ^f  

^a IL   (United States)

^b CELGENE CORPORATION   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Parent Project Muscular Dystrophy   (United States)

^e EMD Serono   (United States)

^f Clinical Trials Transformation Initiative (CTTI)   (United States)

^g WS Collaborative   (United States)

^h Horizon Therapeutics   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j Hyman Phelps & McNamara PC   (United States)

more..

Author keywords

actionable recommendations; best practices; clinical trials; patient group engagement; therapeutic development

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; HEALTH CARE INDUSTRY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; INTERSECTORAL COLLABORATION; MEDICAL EXPERT; PATIENT ADVOCACY; PATIENT GROUP ENGAGEMENT; PATIENT PARTICIPATION; PATIENT PREFERENCE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; SCIENTIST; STRUCTURED INTERVIEW; UNCERTAINTY; COOPERATION; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; MEDICAL RESEARCH; PERSONNEL; UNITED STATES; UNIVERSITY;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; DRUG INDUSTRY; HUMANS; PATIENT PARTICIPATION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RESEARCH PERSONNEL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; UNIVERSITIES;

EID: 85034633866     PISSN: 21684790     EISSN: 21684804     Source Type: Journal    
DOI: 10.1177/2168479017720247     Document Type: Article

References (15)

1. US Food and Drug Administration. Patient-focused drug development. http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm347317.htm. Accessed June 17, 2015.
2. Albarracin D, Gillette JC, Earl AN, Glasman LR, Durantini MR, Ho MH. A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic. Psychol Bull. 2005;131:856–897.
3. Parsons S, Starling B, Mullan-Jensen C, Tham S-G, Warner K, Wever K. What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries. BMJ Open. 2015;5.
4. Pushparajah DS, Geissler J, Westergaard N. EUPATI: collaboration between patients, academia and industry to champion the informed patient in the research and development of medicines. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwifr5TQkZjUAhXGKCYKHaBjA1UQFggkMAA&url=https%3A%2F%2Fwww.eupati.eu%2Fwp-content%2Fuploads%2F2016%2F09%2F2015-07-Journal-Med-Dev-Sciences-EUPATI-Collaboration-between-patients-academia-industry_EN.pdf&usg=AFQjCNGlYRt2IlhBs758wOmeL-N5974yYg&sig2=hIwnuY4eKDavpzP0ncA7kg&cad=rja. Accessed May 30, 2017.
5. Hoos A, Anderson J, Boutin M. Partnering with patients in the development and lifecycle of medicines. Therapeutic Innovation & Regulatory Science. 2015;49:929–939.
6. Pavitt S. EUPATI: an initiative to provide expertise in patient advocacy and in medicines development processes. https://www.eupati.eu/wp-content/uploads/2016/09/2013-09-Regulatory-Rapporteur-September-EUPATI_EN.pdf. Accessed May 30, 2017.
7. Clinical Trials Transformation Initiative. CTTI Membership. https://www.ctti-clinicaltrials.org/membership. Accessed November 3, 2016.
8. Smith SK, Selig W, Harker M. Patient engagement practices in clinical research among patient groups, industry, and academia in the United States: a survey. PLoS One. 2015;10:e0140232.
9. Clinical Trials Transformation Initiative. Patient groups and clinical trials. Meeting materials. http://www.ctti-clinicaltrials.org/what-we-do/ctti-projects/patient-groups/expert-meeting. Accessed November 2, 2016.
10. Clinical Trials Transformation Initiative. Effective engagement with patient groups around clinical trials. Overview and deliverables. http://www.ctti-clinicaltrials.org/what-we-do/projects/patient-groups/products. Accessed November 2, 2016.
11. Clinical Trials Transformation Initiative. CTTI recommendations: effective engagement with patient groups around clinical trials. Recommendations document. https://www.ctti-clinicaltrials.org/files/pgctrecs.pdf. Accessed March 28, 2016.
12. Borup G, Bach KF, Schmiegelow M, Wallach-Kildemoes H, Bjerrum OJ, Westergaard N. A paradigm shift towards patient involvement in medicines development and regulatory science. Therapeutic Innovation & Regulatory Science. 2016;50:304–311.
13. Parsons S, Starling B, Mullan-Jensen C, Tham SG, Warner K, Wever K. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study. BMJ Open. 2016;6:e008928.
14. Levitan B, Getz K, Eisenstein E. Assessing the financial value of patient engagement: a quantitative approach from CTTI’s Patient Groups and Clinical Trials project. Therapeutic Innovation & Regulatory Science. In press.
15. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86–89.